Name: Return on Assets (ROA)

Definition: ROA shows how efficiently the company turns everything it owns — its entire asset base — into net profit after all costs and taxes. A higher ROA means the business squeezes more profit from its assets. Lower ROA might reflect poor asset utilization or heavy reliance on expensive financing.

Interpretation:
• In '2021', NDRA's return on assets was -87.2%, representing returns generated from total assets. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2021' stood at -85.3%.
• In '2022', NDRA's return on assets was -119.0%, representing returns generated from total assets. The decline from '2021' may indicate some operational or financial challenges. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2022' stood at -44.8%. Industry average increased by 40.5% compared to previous year.
• In '2023', NDRA's return on assets was -125.5%, representing returns generated from total assets. The decline from '2022' may indicate some operational or financial challenges. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2023' stood at -61.6%. Industry average declined by 16.8% from previous year.
• In '2024', NDRA's return on assets was -205.4%, representing returns generated from total assets. The decline from '2023' may indicate some operational or financial challenges. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2024' stood at -77.3%. Industry average declined by 15.6% from previous year.
Overall, NDRA's return on assets has been volatile but showed a downward trend over the past 4 years.

Formula: ROA = Net Income / Total Assets

Good Range: Commonly 5%-15%.